PerpEquities

GenScript Biotech Corporation (GENSCRIPT) cash flow statement

HKSE · Healthcare · Biotechnology · 6,135 employees · CEO Weihui Shao

Price
$3.54 0.0%
Market cap
$7.97B
Enterprise value
$8B Data as of 2026-11-21
Last report
Q2 '26 filed 2026-06-30
Next report
2027-03-24

In Q2 '26 GenScript Biotech Corporation (GENSCRIPT) generated $56.7M of operating cash flow, invested $48.3M in capital expenditure and kept $9.1M of free cash flow. Over the last two half-years free cash flow was $50.3M.

Cash flow

Cash flowTrendQ4 '20Q2 '21Q4 '21Q2 '22Q4 '22Q2 '23Q4 '23Q2 '24Q4 '24Q2 '25Q4 '25Q2 '26
Operating
Net income-$91.9M-$91.1M-$268M-$136M-$91.3M-$93.6M-$1.9M-$175M$0-$25.5M-$445M-$129M
Depreciation & amortization$18.8M$23M$24.7M$30M$34.3M$35.5M$38.4M$29.6M$21.3M$35M$39.2M$40.4M
Stock-based compensation$10.2M$14.5M$25.2M$36.5M$28.7M$38.9M$21.7M$53.3M$0$9.58M$5.22M$0
Deferred income tax$77.8M-$58.9M$32.8M-$60.7M-$17.6M-$9M$0$0$0$0$0$0
Change in working capital-$50.9M$60.4M$70.7M$35.7M$96.4M-$56.2M-$94.5M$93.2M$0$69.9M-$1.82M-$36.3M
Other non-cash items-$46M$16.3M$13.3M$32.1M-$109M-$103M-$63.5M$78.9M-$21.3M$144M$495M$182M
Operating cash flow-$82M-$35.9M-$101M-$62M-$58.3M-$187M-$99.7M$79.9M$0$233M$92.9M$56.7M
Investing
Capital expenditure-$63.7M-$68.8M-$64.3M-$73.9M-$142M-$80.2M-$172M-$134M$0-$32.1M-$50M-$48.3M
Acquisitions$0$0$0$0$0$0$0$0$0$0-$8.47M$143K
Purchases of investments$0$0$0$0$0$0$0$0$0$0-$1.16B-$810M
Sales / maturities of investments$0$0$0$0$0$0$0$0$0$0$1.1B$851M
Other investing$75.4M-$100M$20.7M-$263M$35.8M-$374M$269M-$999M$0-$66.5M$48.8M$7.1M
Investing cash flow$11.7M-$169M-$43.6M-$337M-$106M-$455M$96.8M-$1.13B$0-$98.6M-$73.3M$146K
Financing
Net debt issued / repaid$0-$27.8M$0$3.46M$0-$2.4M$0-$22.3M$0$0$85.7M-$7.78M
Share buybacks$0$0$0$0$0$0$0$0$0$0-$225M$0
Other financing (incl. tax on vested shares)-$12.1M$561M$369M$4.77M$411M$1.02B$48.2M$27.8M$0$26.4M$187M-$4.83M
Financing cash flow-$12.1M$533M$369M$8.23M$411M$1.02B$48.2M$5.57M$0$26.4M-$171M-$12.2M
Summary
FX effect on cash$4.67M$343K-$1.23M-$8.08M-$4.62M-$4.97M$3.76M$528K-$3.19B$839K$977K$473K
Net change in cash-$77.6M$329M$223M-$399M$242M$373M$49.1M$399M-$399M$293M-$151M$45.1M
Free cash flow (OCF - capex)-$146M-$105M-$165M-$136M-$200M-$267M-$272M-$54.2M$0$200M$41.2M$9.1M

Standardised from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.

Operating cash flow, capex, free cash flow

quarterly

Uses of cash vs operating cash flow

fiscal years

Share count and EPS

quarterly, diluted

The other statements

Sources

Statements, segment revenue, metrics and estimates are standardised from the company's filings.

Data as of 2026-11-21